New Insight for Enhanced Topical Targeting of Caffeine for Effective Cellulite Treatment: In Vitro Characterization, Permeation Studies, and Histological Evaluation in Rats.

AAPS PharmSciTech 2024 Vol.25(7) p. 237

Fouad SA, Badr TA, Abdelbary A, Fadel M, Abdelmonem R, Jasti BR, El-Nabarawi M

관련 도메인

Abstract

Cellulite (CLT) is one of the commonly known lipodystrophy syndromes affecting post-adolescent women worldwide. It is topographically characterized by an orange-peel, dimpled skin appearance hence, it is an unacceptable cosmetic problem. CLT can be modulated by surgical procedures such as; liposuction and mesotherapy. But, these options are invasive, expensive and risky. For these reasons, topical CLT treatments are more preferred. Caffeine (CA), is a natural alkaloid that is well-known for its prominent anti-cellulite effects. However, its hydrophilicity hinders its cutaneous permeation. Therefore, in the present study CA was loaded into solid lipid nanoparticles (SLNs) by high shear homogenization/ultrasonication. CA-SLNs were prepared using Compritol® 888 ATO and stearic acid as solid lipids, and span 60 and brij™35, as lipid dispersion stabilizing agents. Formulation variables were adjusted to obtain entrapment efficiency (EE > 75%), particle size (PS < 350 nm), zeta potential (ZP < -25 mV) and polydispersity index (PDI < 0.5). CA-SLN-4 was selected and showed maximized EE (92.03 ± 0.16%), minimized PS (232.7 ± 1.90 nm), and optimum ZP (-25.15 ± 0.65 mV) and PDI values (0.24 ± 0.02). CA-SLN-4 showed superior CA release (99.44 ± 0.36%) compared to the rest CA-SLNs at 1 h. TEM analysis showed spherical, nanosized CA-SLN-4 vesicles. Con-LSM analysis showed successful CA-SLN-4 permeation transepidermally and via shunt diffusion. CA-SLN-4 incorporated into Noveon AA-1® hydrogel (CA-SLN-Ngel) showed accepted physical/rheological properties, and in vitro release profile. Histological studies showed that CA-SLN-Ngel significantly reduced mean subcutaneous fat tissue (SFT) thickness with 4.66 fold (p = 0.035) and 4.16 fold (p = 0.0001) compared to CA-gel, at 7th and 21st days, respectively. Also, significant mean SFT thickness reduction was observed compared to untreated group with 4.83 fold (p = 0.0005) and 3.83 fold (p = 0.0043), at 7th and 21st days, respectively. This study opened new avenue for CA skin delivery via advocating the importance of skin appendages. Hence, CA-SLN-Ngel could be a promising nanocosmeceutical gel for effective CLT treatment.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
시술 liposuction 지방흡입 dict 1
해부 skin scispacy 1
해부 vesicles scispacy 1
해부 subcutaneous fat tissue scispacy 1
해부 subcutaneous 피하조직 dict 1
약물 Caffeine C0006644
caffeine
scispacy 1
약물 CLT → Cellulite C0424624
Cellulite
scispacy 1
약물 Compritol scispacy 1
약물 ATO scispacy 1
약물 stearic acid C0038229
stearic acid
scispacy 1
약물 Noveon AA-1 scispacy 1
약물 brij scispacy 1
약물 lipid scispacy 1
질환 Cellulite C0424624
Cellulite
scispacy 1
질환 lipodystrophy syndromes affecting post-adolescent women scispacy 1
질환 orange-peel scispacy 1
질환 polydispersity scispacy 1
질환 solid lipid nanoparticles scispacy 1
질환 SLNs → solid lipid nanoparticles scispacy 1
질환 solid lipids scispacy 1
질환 SFT → subcutaneous fat tissue scispacy 1
기타 Rats scispacy 1
기타 women scispacy 1
기타 Compritol® 888 scispacy 1
기타 PDI scispacy 1
기타 skin appendages scispacy 1

MeSH Terms

Animals; Caffeine; Cellulite; Rats; Nanoparticles; Particle Size; Skin Absorption; Administration, Cutaneous; Skin; Permeability; Lipids; Chemistry, Pharmaceutical; Drug Delivery Systems; Rats, Wistar; Administration, Topical; Drug Carriers; Female; Liposomes

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문